Literature DB >> 18479857

Difficulty of diagnosing Wegener's granulomatosis in the head and neck region.

Kenzo Tsuzuki1, Keijiro Fukazawa, Hironori Takebayashi, Kengo Hashimoto, Masafumi Sakagami.   

Abstract

OBJECTIVE: The objective of this study was to review the various clinical features associated with Wegener's granulomatosis (WG) in the head and neck region and to discuss the difficulty of diagnosing patients with early stage WG.
METHODS: Between January 1998 and August 2007, WG was diagnosed and treated in 16 patients at the Department of Otolaryngology, Hyogo College of Medicine. Clinical and operating records of these patients were analyzed retrospectively. Diagnosis was based on the Japanese criteria proposed by the Japanese Ministry of Health and Welfare in 1998.
RESULTS: Ten patients (62.5%) had a definite diagnosis of WG, and the other six patients (37.5%) had a probable diagnosis of WG. The period from the onset to diagnosis was between 1 month and 30 years. The generalized form of WG was observed in three patients (18.8%), and the limited form of WG was observed in the other 13 patients (81.2%). Nasal, aural, and ophthalmic symptoms were initially presented in 10, 3, and 3 patients, respectively. Cytoplasmic pattern antineutrophil cytoplasmic antibodies (cANCAs) and perinuclear pattern ANCA (pANCA) were positively detected in 68.8% (11/16) and 27.2% (3/11) of the patients, respectively. Five of 14 patients (35.7%) had pathologic features of WG in biopsy samples from the head and neck region. Three patients in whom a diagnosis of WG was difficult are presented, and immediate lessons of our experience were discussed.
CONCLUSIONS: This study emphasized the difficulty of diagnosing WG, particularly at an early stage and when limited to the head and neck region. The biggest challenge faced in diagnosing WG is that it requires a high index of suspicion. When WG was suspected, we should obtain an accurate medical history from patients and repeat serologic and histopathologic examinations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18479857     DOI: 10.1016/j.anl.2008.02.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  [Bilateral deafness and unilateral facial nerve palsy as presenting features of Wegener's granulomatosis : a case report].

Authors:  S Bohne; S Koscielny; H P Burmeister; O Guntinas-Lichius; C Wittekindt
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

2.  Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes.

Authors:  Mara Felicetti; Diego Cazzador; Roberto Padoan; Alfonso Luca Pendolino; Chiara Faccioli; Ennio Nardello; Alvise Berti; Marina Silvestrini; Giuseppe Paolazzi; Giuliano Brunori; Elisabetta Zanoletti; Enzo Emanuelli; Alessandro Martini; Franco Schiavon
Journal:  Clin Rheumatol       Date:  2018-02-20       Impact factor: 2.980

3.  Missed Otological Presentation of Wegener's Granulomatosis: A Case.

Authors:  Ruchika Arora Grover; Ravneet Singh Grover
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-07

4.  Central retinal artery occlusion in Wegener's granulomatosis: a diagnostic dilemma.

Authors:  Virginia Lozano-López; Beatriz Rodríguez-Lozano; María José Losada-Castillo; Esmeralda Delgado-Frías; David Dopazo-Luque; Miguel Serrano-García
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-02-24

5.  Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.

Authors:  Satoshi Ikeda; Machiko Arita; Kenta Misaki; Yumiko Kashiwagi; Yuhei Ito; Hirotaka Yamada; Machiko Hotta; Akihiro Nishiyama; Akihiro Ito; Maki Noyama; Takashi Koyama; Kenji Notohara; Tadashi Ishida
Journal:  BMC Pulm Med       Date:  2015-07-30       Impact factor: 3.317

Review 6.  Epidemiology of vasculitides: differences between Japan, Europe and North America.

Authors:  Shigeto Kobayashi; Shouichi Fujimoto
Journal:  Clin Exp Nephrol       Date:  2013-05-30       Impact factor: 2.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.